Test ID PAINO Pain Clinic Survey 10, Urine
Useful For
Detecting drug use involving amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, phencyclidine, and tetrahydrocannabinol
This test is intended to be used in a setting where the test results can be used to make a definitive diagnosis.
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
PN_10 | Pain Clinic Survey 10 | No | Yes |
OXYSU | Oxycodone Screen, U | Yes | Yes |
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
AMPHU | Amphetamines Confirmation, U | Yes | No |
COKEU | Cocaine and metabolite Conf, U | Yes | No |
BENZU | Benzodiazepines Confirmation, U | Yes | No |
BARBU | Barbiturates Confirmation, U | Yes | No |
MTDNU | Methadone Confirmation, U | Yes | No |
PCPU | Phencyclidine Confirmation, U | Yes | No |
THCU | Carboxy-THC Confirmation, U | Yes | No |
OPATU | Opiate Confirmation, U | Yes | No |
OXYCU | Oxycodone w/metabolite Conf, U | Yes | No |
Testing Algorithm
If immunoassay screen is positive, confirmation is performed. Confirmation with quantification of positives for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, methadone, opiates, phencyclidine, and tetrahydrocannabinol metabolite will be performed at an additional charge. If only oxycodone screen positive, only confirmation of oxycodone w/metabolite will be performed. Any other opiate-positive screen will result in the full opiate confirmation being performed.
Method Name
PN_10, OXYSU: Screened by Immunoassay
Reporting Name
Pain Clinic Survey 10, USpecimen Type
UrineCollection Container/Tube: Plastic urine container
Submission Container/Tube: Plastic, 60-mL urine bottle
Specimen Volume: 30 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Submit 30 mL in 1 plastic bottle.
3. No preservative.
Additional Information:
1. No specimen substitutions.
2. No STATS are accepted for this procedure.
3. For situations where chain of custody is required, a Chain-of-Custody Kit (T282) is available. For chain-of-custody testing, order PANOX / Pain Clinic Survey 10, Chain of Custody, Urine.
4. Additional drug panels and specific requests are available. Call Mayo Medical Laboratories at 800-533-1710 or 507-266-5700.
5. If urine creatinine is required or adulteration of the sample is suspected, the following test should be requested, ADULT / Adulterants Survey, Urine. For additional information, please refer to ADULT / Adulterants Survey, Urine.
6. Submitting less than 30 mL will compromise our ability to perform all necessary testing.
Forms: Chain-of-Custody Request Form is included in the Chain-of-Custody Kit (T282). A copy of this form is also available at http://www.mayomedicallaboratories.com/it-mmfiles/chain-of-custody-request-form.pdf.
Specimen Minimum Volume
20 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Urine | Refrigerated (preferred) | 14 days |
Frozen | 14 days | |
Ambient | 72 hours |
Clinical Information
This assay was designed to test for and confirm by gas chromatography-mass spectrometry (GC-MS) the following:
-Barbiturates
-Benzodiazepines
-Cocaine
-Methadone
-Phencyclidine
-Tetrahydrocannabinol
Confirmation by liquid chromatograph-tandem mass spectrometry (LC-MS/MS) is completed for all opiates and amphetamines.
This test uses the simple screening technique which involves immunologic testing for drugs by class. All positive screening results are confirmed by GC-MS or LC-MS/MS, and quantitated, before a positive result is reported.
Reference Values
Negative
Screening cutoff concentrations:
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 100 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Methadone metabolite: 300 ng/mL
Opiates: 300 ng/mL
Oxycodone: 100 ng/mL
Phencyclidine: 25 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing.
Cautions
Not intended for use in employment-related testing.
For situations where chain of custody is required, a Chain-of-Custody Kit (Supply T282) is available. See PANOX / Pain Clinic Survey 10, Chain of Custody, Urine.
The test does not screen for drug classes other than those listed above. More comprehensive screening is available using the serum or urine drug screens (DSS / Drug Screen, Prescription/OTC, Serum or PDSU / Drug Screen, Prescription/OTC, Urine).
Day(s) Performed
Monday through Friday; Varies
Report Available
2 daysPerforming Laboratory

CPT Code Information
80301
G0479 (if appropriate)